Management's discussion and analysis of results of operations and financial condition highlights the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities. The firm’s IT capabilities represent the application of physical or intangible IT resources such as technology, knowledge, practices, relationships, management skills, and business process understanding to further organizational goals. The long-term success of the company depends significantly on its ability to discover and develop innovative pharmaceutical products and acquire or collaborate on molecules currently in development by other biotechnology or pharmaceutical companies. We strategically invest in external research and technologies that complement and strengthen our own efforts, viewing business development activity as an important way to achieve our strategies and enhance shareholder value. The firm recognizes that various risks and uncertainties may cause actual results, financial position, and cash generated from operations to differ materially from forward-looking statements. The company manages research and development spending across its portfolio of molecules, and a delay in, or termination of, any one project will not necessarily cause a significant change in total research and development spending. The firm’s financial results indicate that revenue and gross margin increased, driven by higher demand for newer pharmaceutical products, while operating expenses decreased due to reduced marketing, selling, and administrative expenses. The company faces challenges related to competition, including the entry of generic products that have caused a rapid and severe decline in revenue for certain products. The firm’s investment decisions are influenced by market dynamics and the need for operational flexibility, as well as the necessity to adapt to changing business needs and directions. The company continues to evaluate business development transactions that have the potential to strengthen its business and enhance its technology portfolio. The firm’s ability to provide data and information to users with appropriate levels of accuracy, timeliness, reliability, and security is crucial for supporting its operational efficiency and strategic resource allocation. The management emphasizes the significance of information management capability in transforming the firm into a competitive force. The company’s financial condition reflects a strong cash position, enabling it to fund short-term borrowing needs and support its commercial paper program. The firm’s strategic alignment with business needs and the integration of technology capabilities into its operations are essential for maintaining market agility and responding effectively to competitive actions. The firm’s governance contexts and regulatory environment also play a critical role in shaping its operational strategies and investment choices. The management's focus on enhancing organizational capabilities and leveraging technology functionalities is aimed at achieving performance excellence and creating business value in a rapidly evolving market landscape.